A laparoscopic sleeve gastrectomy takes about an hour. The patient’s kidney is nowhere near the operative field. An arterial line prints a mean pressure every few seconds, the anaesthetist nudges it with fluid or a vasopressor, the stomach is stapled. The first real look at kidney function comes the next morning, in a creatinine result.
A paper published on 16 November in Obesity Surgery asks whether the answer was in the shape of the curve.
Four shapes, one of which carries the risk
At a single centre in Hefei, the authors reviewed 1,379 adults who had a sleeve between 2016 and 2025, rebuilt mean arterial pressure from invasive readings taken every five minutes, and used latent class mixed modelling to sort patients into groups sharing a trajectory rather than a value.
Four shapes emerged: a moderate decline that then held (492 patients), a steep decline that stayed low (177), a gradual rise (293), and a fall followed by a rebound (417). Recorded acute kidney injury occurred in 78 patients, 5.7%, unevenly spread — 5.1%, 12.4%, 2.7% and 5.5%. Against the rising group, the steep-decline group carried an adjusted odds ratio of 3.21 (95% CI 1.31–7.84); the other two shapes were not individually significant. Discrimination reached a bootstrap-corrected AUC of 0.717. Injury came from database-coded KDIGO labels rather than adjudication; the authors ask for prospective external validation.
What a trajectory class is made of
A latent class is a statistical object: it says patients whose pressures followed a similar arc had similar outcomes, not that the arc caused them — and it tells nobody what to do at 10:40 in the morning. The curve is also a record of decisions taken at the head of the table. A propensity-weighted cohort of 935 sleeve patients, published in October in Drug Design, Development and Therapy, found etomidate induction produced higher time-weighted mean pressure and fewer hypotensive events than other agents, but greater pressure variability and higher C-reactive protein afterwards. A patient’s trajectory is not purely a property of the patient.
The same complication, three counts
The answers are two orders of magnitude apart, and the differences track the instrument rather than the operation. The largest comes from the MBSAQIP registry, analysed for a 2023 paper in Surgery for Obesity and Related Diseases: among 747,926 adults who had a laparoscopic sleeve or bypass between 2015 and 2019 and had no diagnosis of chronic kidney disease, injury was recorded in 446 — 0.05%. Those patients had more complications, readmissions and deaths.
At the Mayo Clinic, a 2025 series in the same journal applied a creatinine definition — a rise of 0.3 mg/dL within 72 hours — to 1,697 primary laparoscopic operations rather than counting codes. The incidence was 3.0%, and predictors were familiar: male sex at an adjusted odds ratio of 3.87, hypertension 2.12, every extra 30 minutes of operating time 1.19. Of the 51 patients, seven needed acute dialysis and three reached chronic renal failure.
Three numbers — 0.05%, 3.0%, 5.7% — and the gap is not a scandal. A billing code records what someone wrote down; a laboratory feed records what was assayed. The registry also excluded the patients most likely to develop injury, so what is measured is ascertainment as much as incidence.
What the trials did with the number
Guidelines recommend keeping mean pressure at 60 to 65 mmHg or above, on the strength of observational links between low pressure and kidney injury. The next question — aim higher, does the kidney do better? — has been asked properly.
A systematic review in Anesthesiology in October 2026 pooled 15 randomised trials covering 15,603 adults having elective noncardiac surgery. Higher targets, fixed or personalised to baseline, did not reduce acute kidney injury: risk ratio 0.95 (95% CI 0.85–1.06), with trial sequential analysis calling the evidence firm. The one positive signal — delirium, risk ratio 0.73 (0.54–0.98) — was judged too uncertain to act on. A second review, in the British Journal of Anaesthesia in August 2026, pooled nine trials and 14,658 patients to the same effect, adding that the arms achieved only limited separation in pressure.
The two literatures do not conflict: low pressure travels with worse kidneys, and raising the target, within the range the trials could achieve, does not fix them. The pressure is a marker of something — volume status, vascular tone, venous congestion — and the trials changed the marker, not the something.
The study that would settle it
What would settle it is unglamorous: protocolised creatinine sampling, pre-specified adjudication and continuous rather than reconstructed haemodynamic data. That is close to the design of the LABS study, funded by NIDDK, whose first phase enrolled 4,776 participants and adjudicated 30-day complications rather than counting codes. But those operations were done in 2005 to 2007, when the sleeve was rare and the bypass and band dominated; the archive of that study remains the template, while the population it described is not the population in the operating room now.
Kidney injury is uncommon, concentrated in patients arriving with hypertension, longer operations, less reserve — and, as our analysis of 30-day readmissions described, dehydration and kidney injury together accounted for 28% of them, making it as much a follow-up problem as an intraoperative one.
The NIDDK’s patient page on side effects, last reviewed in September 2020, lists bleeding, infection, leakage, diarrhoea and blood clots. Kidney injury is not among them — not a failure of the page, but a fair description of where the field’s attention has been. The monitor prints a number every few seconds. What it means for the organ nobody came to operate on is still being worked out.
Sources
- Li S, Zhu C, Zhou J, et al. Intraoperative Mean Arterial Pressure Trajectory Classes and Postoperative Acute Kidney Injury After Sleeve Gastrectomy: A Retrospective Cohort Study. Obesity Surgery, 16 November 2026.
- Qi J, Zheng Z, Gu Y, et al. Effect of Etomidate Induction on Intraoperative Hemodynamics, Postoperative Inflammation, and Recovery After Laparoscopic Sleeve Gastrectomy: A Retrospective Cohort Study. Drug Design, Development and Therapy, 2026;20:655548.
- Valera RJ, Sarmiento-Cobos M, Montorfano L, et al. Predictors and outcomes of acute kidney injury after bariatric surgery: analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program data registry. Surgery for Obesity and Related Diseases, 2023;19(11):1302-1307.
- Abi Mosleh K, Lu L, Salame M, et al. Assessment of predictors of acute kidney injury and progression to chronic kidney disease following bariatric surgery. Surgery for Obesity and Related Diseases, 2025;21(4):382-388.
- Chiou K, Vikram S, Rowshan K, et al. Higher versus Routine Intraoperative Blood Pressure Targets in Noncardiac Surgery: A Systematic Review and Meta-analysis with Trial Sequential Analysis of Randomized Trials. Anesthesiology, 2026;145(4):872-888.
- Sicova M, Alkadri J, Sibley D, et al. Intraoperative hypotension and adverse postoperative outcomes: a systematic review and meta-analysis of randomised controlled trials. British Journal of Anaesthesia, published online 10 August 2026.
- National Institute of Diabetes and Digestive and Kidney Diseases. Weight-loss Surgery Side Effects (last reviewed September 2020).